467 related articles for article (PubMed ID: 18936104)
1. Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat.
Hong S; Fan J; Kemmerer ES; Evans S; Li Y; Wiley JW
Gut; 2009 Feb; 58(2):202-10. PubMed ID: 18936104
[TBL] [Abstract][Full Text] [Related]
2. Corticosterone mediates reciprocal changes in CB 1 and TRPV1 receptors in primary sensory neurons in the chronically stressed rat.
Hong S; Zheng G; Wu X; Snider NT; Owyang C; Wiley JW
Gastroenterology; 2011 Feb; 140(2):627-637.e4. PubMed ID: 21070780
[TBL] [Abstract][Full Text] [Related]
3. Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways.
Zheng G; Hong S; Hayes JM; Wiley JW
Exp Neurol; 2015 Nov; 273():301-11. PubMed ID: 26408049
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of genes that modulate chronic stress-induced visceral pain in the peripheral nervous system.
Hong S; Zheng G; Wiley JW
Gastroenterology; 2015 Jan; 148(1):148-157.e7. PubMed ID: 25263804
[TBL] [Abstract][Full Text] [Related]
5. The endogenous cannabinoid anandamide inhibits transient receptor potential vanilloid type 1 receptor-mediated currents in rat cultured primary sensory neurons.
Sántha P; Jenes A; Somogyi C; Nagy I
Acta Physiol Hung; 2010 Jun; 97(2):149-58. PubMed ID: 20511124
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress.
Surkin PN; Gallino SL; Luce V; Correa F; Fernandez-Solari J; De Laurentiis A
Psychoneuroendocrinology; 2018 Jan; 87():131-140. PubMed ID: 29065362
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the transient receptor potential vanilloid 1 (TRPV1) in the development of acute visceral hyperalgesia during colorectal distension in rats.
Ravnefjord A; Brusberg M; Kang D; Bauer U; Larsson H; Lindström E; Martinez V
Eur J Pharmacol; 2009 Jun; 611(1-3):85-91. PubMed ID: 19344705
[TBL] [Abstract][Full Text] [Related]
8. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.
Malek N; Mrugala M; Makuch W; Kolosowska N; Przewlocka B; Binkowski M; Czaja M; Morera E; Di Marzo V; Starowicz K
Pain; 2015 May; 156(5):890-903. PubMed ID: 25719612
[TBL] [Abstract][Full Text] [Related]
9. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid 1 and transient receptor potential vanilloid 1 receptors discretely modulate evoked glutamate separately from spontaneous glutamate transmission.
Fawley JA; Hofmann ME; Andresen MC
J Neurosci; 2014 Jun; 34(24):8324-32. PubMed ID: 24920635
[TBL] [Abstract][Full Text] [Related]
11. Diabetic thermal hyperalgesia: role of TRPV1 and CB1 receptors of periaqueductal gray.
Mohammadi-Farani A; Sahebgharani M; Sepehrizadeh Z; Jaberi E; Ghazi-Khansari M
Brain Res; 2010 Apr; 1328():49-56. PubMed ID: 20211611
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
[TBL] [Abstract][Full Text] [Related]
13. The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis.
Miranda A; Nordstrom E; Mannem A; Smith C; Banerjee B; Sengupta JN
Neuroscience; 2007 Sep; 148(4):1021-32. PubMed ID: 17719181
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury.
Yang Y; Yang H; Wang Z; Varadaraj K; Kumari SS; Mergler S; Okada Y; Saika S; Kingsley PJ; Marnett LJ; Reinach PS
Cell Signal; 2013 Feb; 25(2):501-11. PubMed ID: 23142606
[TBL] [Abstract][Full Text] [Related]
15. Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy.
Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
Epilepsy Res; 2016 May; 122():56-65. PubMed ID: 26970948
[TBL] [Abstract][Full Text] [Related]
16. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.
Kawahara H; Drew GM; Christie MJ; Vaughan CW
Br J Pharmacol; 2011 Jul; 163(6):1214-22. PubMed ID: 21175570
[TBL] [Abstract][Full Text] [Related]
18. Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation.
Gervasi MG; Osycka-Salut C; Caballero J; Vazquez-Levin M; Pereyra E; Billi S; Franchi A; Perez-Martinez S
PLoS One; 2011 Feb; 6(2):e16993. PubMed ID: 21347292
[TBL] [Abstract][Full Text] [Related]
19. The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor.
Williams MA; Smith SA; O'Brien DE; Mitchell JH; Garry MG
J Physiol; 2008 Feb; 586(3):835-45. PubMed ID: 18063665
[TBL] [Abstract][Full Text] [Related]
20. Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive drg neurons of rats.
Fischbach T; Greffrath W; Nawrath H; Treede RD
J Neurophysiol; 2007 Aug; 98(2):929-38. PubMed ID: 17581853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
